These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 34639229)

  • 1. Electroencephalography as a Non-Invasive Biomarker of Alzheimer's Disease: A Forgotten Candidate to Substitute CSF Molecules?
    Monllor P; Cervera-Ferri A; Lloret MA; Esteve D; Lopez B; Leon JL; Lloret A
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studying the Alzheimer's disease continuum using EEG and fMRI in single-modality and multi-modality settings.
    Li J; Li X; Chen F; Li W; Chen J; Zhang B
    Rev Neurosci; 2024 Jun; 35(4):373-386. PubMed ID: 38157429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early diagnosis of Alzheimer's disease: the role of biomarkers including advanced EEG signal analysis. Report from the IFCN-sponsored panel of experts.
    Rossini PM; Di Iorio R; Vecchio F; Anfossi M; Babiloni C; Bozzali M; Bruni AC; Cappa SF; Escudero J; Fraga FJ; Giannakopoulos P; Guntekin B; Logroscino G; Marra C; Miraglia F; Panza F; Tecchio F; Pascual-Leone A; Dubois B
    Clin Neurophysiol; 2020 Jun; 131(6):1287-1310. PubMed ID: 32302946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Correlate With Electroencephalography Parameters Assessed by Exact Low-Resolution Electromagnetic Tomography (eLORETA).
    Hata M; Tanaka T; Kazui H; Ishii R; Canuet L; Pascual-Marqui RD; Aoki Y; Ikeda S; Sato S; Suzuki Y; Kanemoto H; Yoshiyama K; Iwase M
    Clin EEG Neurosci; 2017 Sep; 48(5):338-347. PubMed ID: 27515698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of Methods of Diagnosis and Complexity Analysis of Alzheimer's Disease Using EEG Signals.
    Ouchani M; Gharibzadeh S; Jamshidi M; Amini M
    Biomed Res Int; 2021; 2021():5425569. PubMed ID: 34746303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometry-based methods for robust measurement of Alzheimer's disease biomarkers in biological fluids.
    Korecka M; Shaw LM
    J Neurochem; 2021 Oct; 159(2):211-233. PubMed ID: 34244999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between the diagnosis method of neuronal dysfunction (DIMENSION) and brain pathology in the early stages of Alzheimer's disease.
    Kouzuki M; Asaina F; Taniguchi M; Musha T; Urakami K
    Psychogeriatrics; 2013 Jun; 13(2):63-70. PubMed ID: 23909962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative EEG power and synchronization correlate with Alzheimer's disease CSF biomarkers.
    Smailovic U; Koenig T; Kåreholt I; Andersson T; Kramberger MG; Winblad B; Jelic V
    Neurobiol Aging; 2018 Mar; 63():88-95. PubMed ID: 29245058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptic Molecular and Neurophysiological Markers Are Independent Predictors of Progression in Alzheimer's Disease.
    Smailovic U; Kåreholt I; Koenig T; Ashton NJ; Winblad B; Höglund K; Nilsson P; Zetterberg H; Blennow K; Jelic V
    J Alzheimers Dis; 2021; 83(1):355-366. PubMed ID: 34334389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of Alzheimer's Disease with Respect to Physiological Aging with Innovative EEG Biomarkers in a Machine Learning Implementation.
    Vecchio F; Miraglia F; Alù F; Menna M; Judica E; Cotelli M; Rossini PM
    J Alzheimers Dis; 2020; 75(4):1253-1261. PubMed ID: 32417784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease.
    Aluise CD; Sowell RA; Butterfield DA
    Biochim Biophys Acta; 2008 Oct; 1782(10):549-58. PubMed ID: 18760351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and effective brain connectivity for discrimination between Alzheimer's patients and healthy individuals: A study on resting state EEG rhythms.
    Blinowska KJ; Rakowski F; Kaminski M; De Vico Fallani F; Del Percio C; Lizio R; Babiloni C
    Clin Neurophysiol; 2017 Apr; 128(4):667-680. PubMed ID: 27836429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers in Alzheimer's disease with a special emphasis on event-related oscillatory responses.
    Yener GG; Başar E
    Suppl Clin Neurophysiol; 2013; 62():237-73. PubMed ID: 24053044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.
    Hampel H; Bürger K; Teipel SJ; Bokde AL; Zetterberg H; Blennow K
    Alzheimers Dement; 2008 Jan; 4(1):38-48. PubMed ID: 18631949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroencephalography Is a Good Complement to Currently Established Dementia Biomarkers.
    Ferreira D; Jelic V; Cavallin L; Oeksengaard AR; Snaedal J; Høgh P; Andersen BB; Naik M; Engedal K; Westman E; Wahlund LO
    Dement Geriatr Cogn Disord; 2016; 42(1-2):80-92. PubMed ID: 27595479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer's Disease: Shortcomings in Prodromal Diagnosis.
    Szalárdy L; Zádori D; Klivényi P; Vécsei L
    J Alzheimers Dis; 2016 May; 53(2):373-92. PubMed ID: 27163812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural biomarker diagnosis and prediction to mild cognitive impairment and Alzheimer's disease using EEG technology.
    Jiao B; Li R; Zhou H; Qing K; Liu H; Pan H; Lei Y; Fu W; Wang X; Xiao X; Liu X; Yang Q; Liao X; Zhou Y; Fang L; Dong Y; Yang Y; Jiang H; Huang S; Shen L
    Alzheimers Res Ther; 2023 Feb; 15(1):32. PubMed ID: 36765411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AD biomarker discovery in CSF and in alternative matrices.
    Sancesario G; Bernardini S
    Clin Biochem; 2019 Oct; 72():52-57. PubMed ID: 31437430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Event-related Potentials Improve the Efficiency of Cerebrospinal Fluid Biomarkers for Differential Diagnosis of Alzheimer's Disease.
    Babić Leko M; Krbot Skorić M; Klepac N; Borovečki F; Langer Horvat L; Vogrinc Ž; Sonicki Z; Hof PR; Šimić G
    Curr Alzheimer Res; 2018; 15(13):1244-1260. PubMed ID: 30207231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Ritchie C; Smailagic N; Noel-Storr AH; Ukoumunne O; Ladds EC; Martin S
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010803. PubMed ID: 28328043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.